Edition:
United States

Cerner Corp (CERN.OQ)

CERN.OQ on NASDAQ Stock Exchange Global Select Market

62.75USD
23 Sep 2016
Change (% chg)

$-0.23 (-0.37%)
Prev Close
$62.98
Open
$62.65
Day's High
$63.18
Day's Low
$62.59
Volume
759,255
Avg. Vol
710,895
52-wk High
$68.31
52-wk Low
$49.60

Latest Key Developments (Source: Significant Developments)

Cerner Corp completes acquisition of Siemens Health Services; gives FY 2015 revenue outlook above analysts' estimates
Monday, 2 Feb 2015 07:20am EST 

Cerner Corp:Announced the completion of its acquisition of Siemens Health Services' assets, client relationships and associates.Says Cerner and the former Siemens business unit have a combined annual research and development investment of more than $650 mln.Says purchase price for the acquisition was $1.3 bln plus working capital adjustments.Expects FY 2015 revenue to be about $4.8 - $5 bln.FY 2015 revenue of $3.8 bln - Thomson Reuters I/B/E/S.  Full Article

Cerner Corp announces agreement to Help Health Care Providers and Patients Better Manage Diabetes
Monday, 3 Nov 2014 08:30am EST 

Cerner Corp:Announced a multi-year agreement with Livongo Health to connect diabetes screening data collected from smart consumer devices with Cerner health care clients.Says for people with diabetes, this can mean more effective self-management and a better use of time with their clinician.Says for care teams, this provides near real-time access to patient information, enabling quick interventions when a patient might be headed toward trouble.  Full Article

Cerner Corp gives Q4 2014 guidance in line with analysts' estimates
Thursday, 23 Oct 2014 04:06pm EDT 

Cerner Corp:Expects Q4 2014 revenue between $880 million and $915 million.Expects Q4 2014 adjusted diluted earnings per share, before share based compensation expense and acquisition costs, between $0.46 and $0.47.Q4 2014 revenue of $904 million and EPS of $0.47 - Thomson Reuters I/B/E/S.  Full Article

BRIEF-Cerner reports Q1 adjusted earnings per share $0.53

* Q1 earnings per share view $0.53 -- Thomson Reuters I/B/E/S